section name header

Indications

REMS

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: QT interval prolongation, heart block, HF, TORSADES DE POINTES.

Derm: acute generalized exanthematous pustulosis, alopecia, DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS), ERYTHEMA MULTIFORME, hair color changes, hyperpigmentation, photosensitivity, pruritus, rash, STEVENS-JOHNSON SYNDROME (SJS), TOXIC EPIDERMAL NECROLYSIS, urticaria.

EENT: corneal deposits, nystagmus, retinopathy, tinnitus, vertigo, visual disturbances.

Endo: hypoglycemia.

GI: ↑ liver enzymes, abdominal pain, anorexia, diarrhea, HEPATOTOXICITY, nausea, vomiting.

GU: proteinuria.

Hemat: AGRANULOCYTOSIS, APLASTIC ANEMIA, leukopenia, thrombocytopenia.

Metab: ↓ weight.

Neuro: aggressiveness, anxiety, ataxia, dizziness, dyskinesia, dystonia, fatigue, headache, irritability, neuromyopathy, nightmares, peripheral neuritis, personality changes, psychoses, SEIZURES, SUICIDAL THOUGHTS/BEHAVIORS, tremor.

Resp: bronchospasm, PULMONARY HYPERTENSION.

Misc: ANGIOEDEMA.

Interactions

Drug-Drug:

Availability

(Generic available)

Route/Dosage

see Calculator

Malaria

Rheumatoid Arthritis

Lupus Erythematosus

US Brand Names

Plaquenil

Action

Therapeutic Effects:

Spectrum:

Classifications

Therapeutic Classification: antimalarials, antirheumatics (DMARDs)

Pharmacokinetics

Absorption: Highly variable (31–100%) following oral administration.

Distribution: Widely distributed; high concentrations in RBCs; crosses the placenta; excreted into breast milk.

Metabolism/Excretion: Partially metabolized by the liver to active metabolites; partially excreted unchanged by the kidneys.

Half-life: 40 days.

Time/Action Profile

(plasma concentrations)

ROUTEONSETPEAKDURATION
POrapid†1–2 hrdays–wk

†Onset of antirheumatic action may take 6 wk.

Patient/Family Teaching

Pronunciation

hye-drox-ee-KLOR-oh-kwin audio

Code

NDC Code*